I. Fischer

发表

Utility of Chromogenic In Situ Hybridization (CISH) for Detection of EGFR Amplification in Glioblastoma: Comparison With Fluorescence In Situ Hybridization (FISH)

K. Aldape, A. Rivera, Andreana L. Rivera, 2008, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

The geldanamycin analogue 17-allylamino-17-demethoxygeldanamycin inhibits the growth of GL261 glioma cells in vitro and in vivo

D. Zagzag, E. Newcomb, Tona Schnee, 2007, Anti-cancer drugs.

Intracranial lesions mimicking neoplasms.

D. Zagzag, M. Law, David J Monoky, 2009, Archives of pathology & laboratory medicine.

Extraventricular subependymal giant cell tumor in a child with tuberous sclerosis complex.

H. Weiner, E. Thiele, R. Bollo, 2009, Journal of neurosurgery. Pediatrics.

High-grade glioma before and after treatment with radiation and Avastin: initial observations.

P. Kelly, J. Golfinos, L. Chiriboga, 2008, Neuro-oncology.

Fluorescent In Situ Hybridization on Isolated Tumor Cell Nuclei: A Sensitive Method for 1p and 19q Deletion Analysis in Paraffin-Embedded Oligodendroglial Tumor Specimens

H. Budka, J. Hainfellner, P. Ambros, 2003, Modern Pathology.

Alterations in homologous recombination repair genes in prostate cancer brain metastases

M. Rubin, U. Amstutz, J. Gallon, 2022, Nature Communications.

Myxoid lipoadenoma of parathyroid gland: a case report and literature review.

Z. Pei, R. Wieczorek, Peng Lee, 2006, Annals of diagnostic pathology.

Magnetic Resonance Imaging Signal Characteristics of Medishield: Early Postoperative Profile in a Rabbit Interlaminotomy Model.

J. Fandino, L. Remonda, D. Coluccia, 2017, World Neurosurgery.

Ki-67 Immunolabeling Index Is an Accurate Predictor of Outcome in Patients With Intracranial Ependymoma

H. Budka, J. Hainfellner, I. Slavc, 2004, The American journal of surgical pathology.

Sellar Toxoplasmosis and Nonfunctioning Pituitary Adenoma.

J. Fandino, S. Berkmann, I. Fischer, 2015, World neurosurgery.

Synchronous mixed germ cell tumor of the pineal gland and suprasellar region with a predominant angiomatous component: a diagnostic challenge

J. Wisoff, Jeffrey C. Allen, D. Zagzag, 2009, Journal of Neuro-Oncology.

Residual nonfunctioning pituitary adenomas: prognostic value of MIB-1 labeling index for tumor progression.

J. Hainfellner, M. Preusser, E. Knosp, 2009, Journal of neurosurgery.

Molecular tools: biology, prognosis, and therapeutic triage.

K. Aldape, I. Fischer, 2010, Neuroimaging clinics of North America.

Angiogenesis in Gliomas: Imaging and Experimental Therapeutics

D. Zagzag, E. Newcomb, M. Law, 2005, Brain pathology.

Prognostic relevance of p53 protein expression in glioblastoma.

C. Marosi, H. Budka, J. Hainfellner, 2002, Oncology reports.

Vascular Patterns in Glioblastoma Influence Clinical Outcome and Associate with Variable Expression of Angiogenic Proteins: Evidence for Distinct Angiogenic Subtypes

Markus Bredel, Peter F Ambros, Herbert Budka, 2003, Brain pathology.

The Genomic Landscape of Prostate Cancer Brain Metastases

M. Rubin, U. Amstutz, J. Gallon, 2020, bioRxiv.

ALS‐associated fused in sarcoma (FUS) mutations disrupt Transportin‐mediated nuclear import

I. Mackenzie, C. Haass, M. Neumann, 2010, The EMBO journal.

Glioma-like proliferation within tissues excised as tubers in patients with tuberous sclerosis complex

Douglas C. Miller, H. Ostrer, O. Devinsky, 2008, Acta Neuropathologica.

Angiogenesis in Gliomas: Biology and Molecular Pathophysiology

D. Zagzag, E. Newcomb, M. Law, 2005, Brain pathology.

State-of-the-Art New WHO Classification, Implications, and New Developments

Clare H. Cunliffe, Ingeborg Fischer, Yoav Parag, 2010 .

Feasibility of using bevacizumab with radiation therapy and temozolomide in newly diagnosed high-grade glioma.

P. Kelly, J. Golfinos, E. Knopp, 2008, International journal of radiation oncology, biology, physics.

Ki67 index in intracranial ependymoma: a promising histopathological candidate biomarker

S Wolfsberger, M Preusser, H. Heinzl, 2008, Histopathology.

Use of fluorescence to guide resection or biopsy of primary brain tumors and brain metastases.

Lucia Schwyzer, Daniel Coluccia, Javier Fandino, 2014, Neurosurgical focus.

State-of-the-art pathology: new WHO classification, implications, and new developments.

M. Fowkes, C. Cunliffe, I. Fischer, 2010, Neuroimaging clinics of North America.

Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival.

P. Kelly, G. Johnson, J. Golfinos, 2009, Journal of neurosurgery.

High expression of DNA topoisomerase IIalpha and Ki-67 antigen is associated with prolonged survival in glioblastoma patients.

C. Marosi, H. Budka, M. Bredel, 2002, European journal of cancer.

Bevacizumab therapy in recurrent high grade glioma: Impact on local control and survival

G. Johnson, J. Golfinos, E. Knopp, 2008 .

Nucleus-specific alteration of raphe neurons in human neurodegenerative disorders

H. Budka, S. Klöppel, B. Volk, 2003, Neuroreport.

Utility of Chromogenic In Situ Hybridization (CISH) for Detection of EGFR Amplification in Glioblastoma: Comparison With Fluorescence In Situ Hybridization (FISH)

K. Aldape, Andreana L. Rivera, I. Fischer, 2008, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

Use of fluorescence to guide resection or biopsy of primary brain tumors and brain metastases.

J. Fandino, U. Roelcke, D. Coluccia, 2014, Neurosurgical focus.

Rare suprasellar glioblastoma: report of two cases and review of the literature

S. Kollias, R. Bernays, E. Rushing, 2012, Brain Tumor Pathology.

Intracranial lesions mimicking neoplasms.

D. Zagzag, M. Law, David J Monoky, 2009, Archives of pathology & laboratory medicine.